May 22, 2023
(press release)
–
Azelis, a leading innovation service provider in the specialty chemicals and food ingredients industry, is pleased to announce its new agreement with MANE, a leading fragrance and flavor house, for the distribution of its flavors and taste solutions in Denmark, Norway, and Sweden. Effective immediately, this mandate expands the existing partnership between Azelis and MANE in France, the UK, Ireland, Benelux, and Turkey. With MANE being world-renowned for its extensive range of flavors and taste solutions, this agreement allows Azelis to broaden its product offering in the Food & Nutrition market. The partnership is in line with Azelis’ strategy of organic growth with its key partners. Renaud Milliard, EMEA Sales Director Distribution Flavors at MANE, comments: “MANE has been present in the flavor and taste markets for several years and will maintain its direct engagement to strategic accounts. The extension of the partnership with Azelis enables us to reinforce our presence in the Scandinavian markets and to offer additional services for the clients. As we have seen in the past, joining forces with Azelis is beneficial both for us as a principal as well as for customers.” Gert Schnoor, Managing Director at Azelis Nordic, adds: “We are pleased to be MANE's exclusive partner in the Scandinavian countries, giving us the opportunity to introduce their high-quality products to the Food & Nutrition market in this region and strengthening our lateral value chain. This deal confirms the strong collaboration between the two companies, the shared values, and the joint efforts of both MANE and Azelis in terms of innovation and sustainability. We look forward to bringing our technical expertise to our customers, to best meet their current needs.”
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
